Does Influenza Vaccination Benefit Patients Hospitalized With Diabetes?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?
Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.
Physical activity and acute exercise offer some benefit for influenza vaccination response, according to a review published online.
A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
Researchers evaluated the risk of confounding bias in simulated test-negative studies that assessed estimated COVID-19 and influenza vaccine effectiveness.
In patients with severe pneumonia, how do clinical characteristics, comorbidities, and mortality rates differ between those with vs without COVID-19?
Researchers conducted a study that compared early treatment with inhaled zanamivir vs oral oseltamivir on the risk for hospitalization or death due to influenza infection.
For children aged 5 to 17 years with asthma, quadrivalent live attenuated influenza vaccine (LAIV4) is noninferior to quadrivalent inactivated influenza vaccine (IIV4) for frequency of asthma exacerbations.
There is a small absolute risk for shoulder conditions after intramuscular vaccination administered in the deltoid muscle.